Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) (351174)

From US Department of Health & Human Services: National Institutes of Health (NIH)

The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

Type of Support

Overview

The grant program outlined emphasizes the importance of punctuality in application submissions, with a specific closing time of 5:00 PM local time for the applicant organization. It also suggests, though does not mandate, that Letters of Intent be submitted 30 days prior to the full proposal deadline, aiming to streamline the process and possibly enhance the applicant's chance of success by indicating their interest and intentions early in the application process. Specific goals or causes supported by the grant are not mentioned in the provided details.

Eligibility

Organization's Location
tempor cupidatat
Program Location
Lorem
Organization Type
up to 450k

Submission

Visit Apply for more information.

Similar grants